As international development partners reduce funding for family planning (FP) programs, the need to estimate the financial resources devoted to FP is becoming increasingly important both at all levels. This cross-sectional assessment examined the FP financing sources, agents, and expenditures in two counties of Kenya for fiscal years 2010/2011 and 2011/2012 to guide local decision-making on financial allocations. Data were collected through a participatory process. This involved stakeholder interviews, review of financial records and service statistics, and a survey of facilities offering FP services. Financing sources and agents were identified, and source amounts calculated. Types of FP provider organizations and the amounts spent by expenditure categories were identified. Overall, five financing sources and seven agents for FP were identified. Total two-year expenditures were KSh 307.8 M (US$ 3.62 M). The government's share of funding rose from 12% to 21% over the two years (p=0.029). In 2010/2011, the largest expense categories were administration, commodities, and labor; however, spending on commodities increased by 47% (p=0.042). This study provides local managers with FP financing and expenditure information for use in budget allocation decision-making. These analyses can be done routinely and replicated in other local counties or countries in a context of devolution.

Download full-text PDF

Source
http://dx.doi.org/10.29063/ajrh2017/v21i4.3DOI Listing

Publication Analysis

Top Keywords

financing sources
12
sources agents
12
family planning
8
agents identified
8
changing face
4
face family
4
planning funding
4
funding kenya
4
kenya cross-sectional
4
cross-sectional survey
4

Similar Publications

This article describes data from an online survey conducted with the Swiss public from the two biggest language regions (German and French) in Switzerland. The survey was conducted in February 2023. Participants were recruited through a professional panel provider and quotas were used for age, gender and language region.

View Article and Find Full Text PDF

Measuring the consumption of processed foods made from a common raw agricultural ingredient requires to make quantities comparable, by converting them in raw product equivalent. This conversion also allows to compute total quantities. In the case of legumes, the challenge is to take into account a wide diversity of final products including packaged dry legumes, processed legumes and products cooked from legumes and other ingredients.

View Article and Find Full Text PDF

Farming practices such as soil tillage, organic/mineral fertilization, irrigation, crop selection and residues management influence multiple ecosystem services provided by agricultural systems. These practices exhibit complex, non-linear interrelationships that affect crop productivity, water quality, and non-carbon dioxide greenhouse gases (GHG) emissions, possibly offsetting their benefits regarding soil organic carbon (SOC) sequestration. Current methodologies from the Intergovernmental Panel on Climate Change (IPCC) for assessing the impacts of alternative farming practices on GHG emissions rely on global or country-specific coefficients.

View Article and Find Full Text PDF

Objective: Identify differences in Medicare reimbursement changes for general otolaryngology, pediatric otolaryngology, head and neck oncology, laryngology, rhinology, otology, facial plastic and reconstructive surgery, and sleep surgery subspecialties from 2013 to 2024.

Methods: Subspecialty-based procedures' facility prices and relative value units (RVUs) were sourced from the Centers for Medicare & Medicaid Services' Physician Fee Schedule. Prices were adjusted for inflation, and the average percent change in facility price and RVUs for each subspecialty was calculated.

View Article and Find Full Text PDF

Background: Innovative health technologies have increasingly emerged as a promising solution for patients with untreatable or challenging conditions. However, these technologies often come with expensive costs and limited evidence at the time of launch. This study assessed how these high-priced drugs with limited evidence were appraised and introduced in South Korea, England, Australia, and Canada, where cost-effectiveness analysis (CEA) generally plays a central role in pricing and reimbursement decisions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!